|
1
|
Chen W, Wu Q, Mo L and Nassi M:
Intra-arterial chemotherapy is not superior to intravenous
chemotherapy for malignant gliomas: A systematic review and
meta-analysis. Eur Neurol. 70:124–132. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bregy A, Shah AH, Diaz MV, Pierce HE, Ames
PL, Diaz D and Komotar RJ: The role of Gliadel wafers in the
treatment of high-grade gliomas. Expert Rev Anticancer Ther.
13:1453–1461. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yin AA, Cai S, Dong Y, Zhang LH, Liu BL,
Cheng JX and Zhang X: A meta-analysis of temozolomide versus
radiotherapy in elderly glioblastoma patients. J Neurooncol.
116:315–324. 2014. View Article : Google Scholar
|
|
4
|
Yin AA, Zhang LH, Cheng JX, Dong Y, Liu
BL, Han N and Zhang X: Radiotherapy plus concurrent or sequential
temozolomide for glioblastoma in the elderly: A meta-analysis. PLoS
One. 8:e742422013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang Y and Jiang T: Understanding high
grade glioma: Molecular mechanism, therapy and comprehensive
management. Cancer Lett. 331:139–146. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schneider AJ, Branam AM and Peterson RE:
Intersection of AHR and Wnt signaling in development, health, and
disease. Int J Mol Sci. 15:17852–17885. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim SA, Kwak J, Nam HY, Chun SM, Lee BW,
Lee HJ, Khang SK and Kim SW: Promoter methylation of WNT inhibitory
factor-1 and expression pattern of WNT/β-catenin pathway in human
astrocytoma: Pathologic and prognostic correlations. Mod Pathol.
26:626–639. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu J, Fang J, Yang Z, Chen F, Liu J and
Wang Y: Wnt inhibitory factor-1 regulates glioblastoma cell cycle
and proliferation. J Clin Neurosci. 19:1428–1432. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang Z and Wang Y, Fang J, Chen F, Liu J,
Wu J and Wang Y: Expression and aberrant promoter methylation of
Wnt inhibitory factor-1 in human astrocytomas. J Exp Clin Cancer
Res. 29:262010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang YM, Meng ZZ, Yue GX and Chen JX:
Norcantharidin induces HL-60 cell apoptosis in vitro. Evid Based
Complement Alternat Med. 2012:1542712012. View Article : Google Scholar
|
|
11
|
Clevers H, Loh KM and Nusse R: Stem cell
signaling. An integral program for tissue renewal and regeneration:
Wnt signaling and stem cell control. Science. 346:12480122014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jamieson C, Sharma M and Henderson BR:
Targeting the β-catenin nuclear transport pathway in cancer. Semin
Cancer Biol. 27:20–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Le PN, McDermott JD and Jimeno A:
Targeting the Wnt pathway in human cancers: therapeutic targeting
with a focus on OMP-54F28. Pharmacol Ther. 146:1–11. 2015.
View Article : Google Scholar
|
|
14
|
Bilir B, Kucuk O and Moreno CS: Wnt
signaling blockage inhibits cell proliferation and migration, and
induces apoptosis in triple-negative breast cancer cells. J Transl
Med. 11:2802013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen X, Hu W, Xie B, Gao H, Xu C and Chen
J: Downregulation of SCAI enhances glioma cell invasion and stem
cell like phenotype by activating Wnt/β-catenin signaling. Biochem
Biophys Res Commun. 448:206–211. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schüle R, Dictus C, Campos B, Wan F,
Felsberg J, Ahmadi R, Centner FS, Grabe N, Reifenberger G, Bermejo
JL, et al: Potential canonical wnt pathway activation in high-grade
astrocytomas. Sci World J. 2012:6973132012. View Article : Google Scholar
|
|
17
|
Wang K, Wang X, Zou J, Zhang A, Wan Y, Pu
P, Song Z, Qian C, Chen Y, Yang S, et al: miR-92b controls glioma
proliferation and invasion through regulating Wnt/beta-catenin
signaling via Nemo-like kinase. Neuro-oncol. 15:578–588. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Delic S, Lottmann N, Stelzl A, Liesenberg
F, Wolter M, Götze S, Zapatka M, Shiio Y, Sabel MC, Felsberg J, et
al: MiR-328 promotes glioma cell invasion via SFRP1-dependent
Wnt-signaling activation. Neuro-oncol. 16:179–190. 2014. View Article : Google Scholar :
|
|
19
|
Liu D, Shi P, Yin X, Chen Z and Zhang X:
Effect of norcantharidin on the human breast cancer Bcap-37 cells.
Connect Tissue Res. 53:508–512. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee YC, Lee LM, Yang CH, Lin AM, Huang YC,
Hsu CC, Chen MS, Chi CW, Yin PH, Kuo CD, et al: Norcantharidin
suppresses cell growth and migration with enhanced anticancer
activity of gefitinib and cisplatin in human non-small cell lung
cancer cells. Oncol Rep. 29:237–243. 2013.
|
|
21
|
Liao HF, Chen YJ, Chou CH, Wang FW and Kuo
CD: Norcantharidin induces cell cycle arrest and inhibits
progression of human leukemic Jurkat T cells through
mitogen-activated protein kinase-mediated regulation of
interleukin-2 production. Toxicol In Vitro. 25:206–212. 2011.
View Article : Google Scholar
|
|
22
|
Liu S, Yu H, Kumar SM, Martin JS, Bing Z,
Sheng W, Bosenberg M and Xu X: Norcantharidin induces melanoma cell
apoptosis through activation of TR3 dependent pathway. Cancer Biol
Ther. 12:1005–1014. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shen B, He PJ and Shao CL: Norcantharidin
induced DU145 cell apoptosis through ROS-mediated mitochondrial
dysfunction and energy depletion. PLoS One. 8:e846102013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shou LM, Zhang QY, Li W, Xie X, Chen K,
Lian L, Li ZY, Gong FR, Dai KS, Mao YX, et al: Cantharidin and
norcantharidin inhibit the ability of MCF-7 cells to adhere to
platelets via protein kinase C pathway-dependent downregulation of
α2 integrin. Oncol Rep. 30:1059–1066. 2013.PubMed/NCBI
|
|
25
|
An WW, Gong XF, Wang MW, Tashiro S,
Onodera S and Ikejima T: Norcantharidin induces apoptosis in HeLa
cells through caspase, MAPK, and mitochondrial pathways. Acta
Pharmacol Sin. 25:1502–1508. 2004.PubMed/NCBI
|
|
26
|
Yu CC, Ko FY, Yu CS, Lin CC, Huang YP,
Yang JS, Lin JP and Chung JG: Norcantharidin triggers cell death
and DNA damage through S-phase arrest and ROS-modulated apoptotic
pathways in TSGH 8301 human urinary bladder carcinoma cells. Int J
Oncol. 41:1050–1060. 2012.PubMed/NCBI
|
|
27
|
Zhang L, Ji Q, Liu X, Chen X, Chen Z, Qiu
Y, Sun J, Cai J, Zhu H and Li Q: Norcantharidin inhibits tumor
angiogenesis via blocking VEGFR2/MEK/ERK signaling pathways. Cancer
Sci. 104:604–610. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang S, Li G, Ma X, Wang Y, Liu G, Feng
L, Zhao Y, Zhang G, Wu Y, Ye X, et al: Norcantharidin enhances
ABT-737-induced apoptosis in hepatocellular carcinoma cells by
transcriptional repression of Mcl-1. Cell Signal. 24:1803–1809.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang JT, Sun W, Zhang WZ, Ge CY, Liu ZY,
Zhao ZM, Lu XS and Fan YZ: Norcantharidin inhibits tumor growth and
vasculogenic mimicry of human gallbladder carcinomas by suppression
of the PI3-K/MMPs/Ln-5γ2 signaling pathway. BMC Cancer. 14:1932014.
View Article : Google Scholar
|
|
30
|
Chen S, Wan P, Ding W, Li F, He C, Chen P,
Li H, Hu Z, Tan W and Li J: Norcantharidin inhibits DNA replication
and induces mitotic catastrophe by degrading initiation protein
Cdc6. Int J Mol Med. 32:43–50. 2013.PubMed/NCBI
|
|
31
|
Pitre A, Davis N, Paul M, Orr AW and
Skalli O: Synemin promotes AKT-dependent glioblastoma cell
proliferation by antagonizing PP2A. Mol Biol Cell. 23:1243–1253.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zheng J, Du W, Song LJ, Zhang R, Sun LG,
Chen FG and Wei XT: Norcantharidin induces growth inhibition and
apoptosis of glioma cells by blocking the Raf/MEK/ERK pathway.
World J Surg Oncol. 12:2072014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu MY, Xie X, Xu ZK, Xie L, Chen Z, Shou
LM, Gong FR, Xie YF, Li W and Tao M: PP2A inhibitors suppress
migration and growth of PANC-1 pancreatic cancer cells through
inhibition on the Wnt/β-catenin pathway by phosphorylation and
degradation of β-catenin. Oncol Rep. 32:513–522. 2014.PubMed/NCBI
|
|
34
|
Chuang KA, Lieu CH, Tsai WJ, Wu MH, Chen
YC, Liao JF, Wang CC and Kuo YC: Evaluation of anti-Wnt/β-catenin
signaling agents by pGL4-TOP transfected stable cells with a
luciferase reporter system. Braz J Med Biol Res. 43:931–941. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hsieh CH, Chao KS, Liao HF and Chen YJ:
Norcantharidin, derivative of cantharidin, for cancer stem cells.
Evid Based Complement Alternat Med. 2013:8386512013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu YL, Yang HP, Zhou XD, Gong L, Tang CL
and Wang HJ: The hypomethylation agent bisdemethoxycurcumin acts on
the WIF-1 promoter, inhibits the canonical Wnt pathway and induces
apoptosis in human non-small-cell lung cancer. Curr Cancer Drug
Targets. 11:1098–1110. 2011. View Article : Google Scholar : PubMed/NCBI
|
